Fate Therapeutics GAAP EPS of -$0.32 beats by $0.07, revenue of $1.63M beats by $0.45M Fate Therapeutics GAAP EPS of -$0.32 beats by $0.07, revenue of $1.63M beats by $0.45M Post ContentfateRead More You might also be interested in reading UnitedHealth drops as CEO steps down; suspends guidance. May 13, 2025 In Mainstream ← Previous post Next post →